MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/egastro-2025-100334

Медицинская библиотека · eGastroenterology · 2026

Exercise and dietary interventions ameliorate MASLD via the hepatic PPARγ-miR-802-Psmd2 axis.

Liu Yingying, Liu Jingjing, Song Ping, Sun Lin, Fang Zhiqiang, Yue Zhensheng, Duan Juanli, He Fei, Wang Lin

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

MicroRNAs critically regulate metabolic dysfunction-associated steatotic liver disease (MASLD) progression and intervention. Lifestyle modifications, particularly exercise and time-restricted feeding (TRF), emerge as effective non-pharmacological strategies.

METHODS

MiR-802 expression was quantified in plasma exosomes and hepatic tissues of MASLD mouse models using quantitative PCR and sequencing. In vivo and in vitro gain-of-function and loss-of-function experiments assessed its regulatory effects on hepatic lipotoxicity, complemented by bioinformatic predictions and luciferase-based validation of upstream transcription factors and downstream targets. Functional crosstalk between miR-802 and its regulatory network was examined under lipotoxic conditions. Therapeutic interventions, including exercise and TRF, were implemented in high-fat diet fed mice, with subsequent evaluation of miR-802 expression dynamics.

RESULTS

Here, we show elevated miR-802 levels in plasma exosomes and livers of MASLD mice, with its inhibition reducing hepatocyte lipotoxicity. Mechanistically, peroxisome proliferator-activated receptor gamma (PPARγ) promotes miR-802 transcription, whereas miR-802 suppresses the proteasome 26S subunit ubiquitin receptor, non-ATPase 2 (Psmd2). Genetic and pharmacological modulation of PPARγ downregulates miR-802 and ameliorates MASLD. Notably, both exercise and TRF reduce hepatic PPARγ and miR-802 expression and improve MASLD via the PPARγ-miR-802-Psmd2 axis, revealing lifestyle modification-mediated epigenetic regulation in MASLD pathophysiology.

CONCLUSION

This study reveals the PPARγ-miR-802-Psmd2 axis as a central regulatory mechanism in MASLD pathogenesis and innovatively links lifestyle interventions (exercise and TRF) to therapeutic effects via this pathway.

Для цитирования: Liu Yingying, Liu Jingjing, Song Ping, Sun Lin, Fang Zhiqiang, Yue Zhensheng, Duan Juanli, He Fei, Wang Lin. Exercise and dietary interventions ameliorate MASLD via the hepatic PPARγ-miR-802-Psmd2 axis.. eGastroenterology. 2026. DOI: 10.1136/egastro-2025-100334.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.